Jesper Gromada

Jesper Gromada

Private Equity Investor at
Third Rock Ventures LLC
Health Technology
Consumer Services
Finance

Profile

Jesper Gromada is currently a Venture Partner at Third Rock Ventures LLC since 2022.
Former positions include Associate Director at Eli Lilly & Co. from 2000 to 2006, VP - Muscle and Metabolism Therapeutic Areas at Regeneron Pharmaceuticals, Inc. from 2012 to 2018, Chief Scientific Officer at Exonics Therapeutics, Inc. from 2018 to 2019, Site Head-Vertex Genetic Therapies at Vertex Pharmaceuticals, Inc. from 2019 to 2020, and Chief Scientific Officer at Laronde, Inc. from 2020 to 2022.
Education includes a doctorate from the University of Copenhagen conferred in 1995.

Jesper Gromada active positions

CompaniesPositionStart
Private Equity Investor 01/09/2022

Former positions of Jesper Gromada

CompaniesPositionEnd
Corporate Officer/Principal 01/09/2022
VERTEX PHARMACEUTICALS INCORPORATED Corporate Officer/Principal 01/10/2020
Corporate Officer/Principal 01/07/2019
REGENERON PHARMACEUTICALS, INC. Corporate Officer/Principal 01/10/2018
ELI LILLY AND COMPANY Corporate Officer/Principal 01/01/2006
See the detail of Jesper Gromada's experience

Training of Jesper Gromada

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

76

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies7

Health Technology

Health Technology

Health Technology

Consumer Services

Finance

Health Technology

Commercial Services

  1. Stock Market
  2. Insiders
  3. Jesper Gromada